4.7 Review

Causes of Vaccine Hesitancy in Adults for the Influenza and COVID-19 Vaccines: A Systematic Literature Review

Journal

VACCINES
Volume 10, Issue 9, Pages -

Publisher

MDPI
DOI: 10.3390/vaccines10091518

Keywords

vaccine hesitancy; adults; influenza; COVID-19

Funding

  1. National Institute for Health Research (NIHR) Imperial Patient Safety Translational Research Centre [PSTRC-2016-004]

Ask authors/readers for more resources

This review identifies the causes of vaccine hesitancy related to the COVID-19 and influenza vaccines. The findings suggest that concerns over safety, lack of trust, lack of need for vaccination, and cultural reasons contribute to vaccine hesitancy. Scientific knowledge and the size of clinical trials can reduce vaccine hesitancy, but pharmaceutical companies are not trusted sources of information.
Background: Vaccine hesitancy was labelled as one of the top ten threats to global health by the World Health Organization in 2019 and is associated with negative health outcomes. Previous reviews on cause of vaccines have not included vaccine hesitancy related to the COVID-19 vaccine. This review aimed to fill this gap by synthesising the findings of studies identifying causes of vaccine hesitancy to the COVID-19 and influenza vaccines. Methods: A systematic literature review was conducted. Searches were carried out in the PubMed, EMBASE and Cochrane databases. Following data extraction, a thematic analysis was conducted of the causes of vaccine hesitancy in adults for the influenza and COVID-19 vaccines. Results: Fourteen papers were included. Four themes were identified as causes of vaccine hesitancy comprising: concerns over safety, lack of trust, lack of need for vaccination and cultural reasons. While concerns over safety were found in all countries, some of these were specific to particular countries and cultures. Our findings suggest that scientific knowledge of vaccines and size of clinical trials during their development reduce vaccine hesitancy. However, pharmaceutical companies were not a trusted source of information. Conclusion: Our findings build on those of previous research to suggest specific information that may be helpful in addressing vaccine hesitancy. Targeted approaches from trusted sources are needed to address specific safety concerns.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available